Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Wilma L Lingle Edith A. Perez Amylou Dueck |
| Publication date | June 6, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |